logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Vidarabine Monophosphate CAS 29984-33-6

Vidarabine Monophosphate CAS 29984-33-6

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 29984-33-6

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
29984-33-6
Appearance::
White Crystalline Powder
Molecular Formula::
C10H14N5O7P
Molecular Weight::
347.22100
EINECS NO::
249-990-8
MDL NO::
MFCD00069723
CAS NO::
29984-33-6
Appearance::
White Crystalline Powder
Molecular Formula::
C10H14N5O7P
Molecular Weight::
347.22100
EINECS NO::
249-990-8
MDL NO::
MFCD00069723
Vidarabine Monophosphate CAS 29984-33-6

Product Description:

Product Name: Vidarabine monophosphate CAS NO: 29984-33-6

 

 

Synonyms:

9-(5-O-Phosphono-β-D-arabinofuranosyl)-9H-purin-6-amine;

9H-Purin-6-amine, 9-(5-O-phosphono-b-D-arabinofuranosyl)-;

Adenosin-5'-phosphat;

 

 

Chemical & Physical Properties:

Appearance: White crystalline powder.

Assay :≥99.0%

Density: 2.32 g/cm3

Boiling Point: 798.5℃ at 760 mmHg

Melting Point: 213℃

Stability: Stable under normal temperatures and pressures.

Storage Condition: Store at 0℃

Vapor Pressure: 6.7E-27mmHg at 25℃

 

 

Safety Information:

Hazard Class: 6.1(a)

Safety Statements: S24/25-S37/39

Packing Group: II

RIDADR: UN 2811

Risk Statements: R20/22

Hazard Codes: Xn,Xi,T

 

 

Vidarabine phosphate is an adenosine monophosphate nucleotide in which ribose is replaces by an arabinso moiety. It has antiviral and possibly antineoplastic properties.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.